Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Starlight Therapeutics Inc.

Clinical trials sponsored by Starlight Therapeutics Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug combo aims to fight returning brain tumors Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New drug combo aims to fight returning brain tumors

Disease control Not yet recruiting

This early-stage trial tests a new drug called STAR-001 combined with the blood pressure medication spironolactone in about 68 people whose glioblastoma has returned after initial treatment. The goal is to see if the combination is safe and can shrink tumors. Participants receive…

Phase 1/2 • Sponsor: Starlight Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC